New first-line immunotherapy-based combinations for metastatic renal cell carcinoma: A systematic review and network meta-analysis
2022 · Cancer Treatment Reviews · 39 citations
https://doi.org/10.1016/j.ctrv.2022.102377
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
71
Papers
758
Citations
13
h-index
15
i10-index
Rossella Di Bidino is an academic researcher from Università Cattolica del Sacro Cuore. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Pharmaceutical Economics and Policy & Quality and Safety in Healthcare. The author has an h-index of 13, co-authored 61 publications.
ORCID: 0000-0001-9773-856Xhttps://doi.org/10.1016/j.ctrv.2022.102377
https://doi.org/10.1017/s0266462325000108
Click to start Chat